Hematopoietic Stem Cell Transplantation for Bone Marrow Failure Syndromes in Children

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 3, 2009, Pages 279-292

  Myers, Kasiani C ^a   Davies, Stella M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Bone marrow failure; Children; Fanconi; Transplantation

Indexed keywords

ALEMTUZUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; MELPHALAN; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; APLASTIC ANEMIA; BLACKFAN DIAMOND ANEMIA; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CELL LINE; CHILD; CHILD HEALTH CARE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOPENIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DONOR SELECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKERATOSIS CONGENITA; EPSTEIN BARR VIRUS; FAMILY COUNSELING; FANCONI ANEMIA; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART FAILURE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; HYPERVOLEMIA; LOW DRUG DOSE; LUNG INSUFFICIENCY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MONOTHERAPY; MUCOSA INFLAMMATION; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; OSTEOSARCOMA; OVARY INSUFFICIENCY; PATHOPHYSIOLOGY; PATIENT CARE; PERIPHERAL BLOOD STEM CELL; PROGNOSIS; RADIATION PNEUMONIA; RASH; RECURRENCE RISK; REDUCED INTENSITY CONDITIONING; REVIEW; SHWACHMAN SYNDROME; SIBLING; TESTIS DISEASE; THROMBOCYTOPENIA; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW DISEASES; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT;

EID: 59349117687     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.11.037     Document Type: Review

References (144)

1. Shimamura A., and Guinan E. Acquired Aplastic Anemia (2003), WB Saunders, Philadelphia
2. Camitta B.M., Thomas E.D., Nathan D.G., et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53 (1979) 504-514
3. Storb R., Thomas E.D., Buckner C.D., et al. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia. Ann Intern Med 92 (1980) 30-36
4. Kojima S., Fukuda M., Miyajima Y., et al. Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood 77 (1991) 937-941
5. Young N.S., Calado R.T., and Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108 (2006) 2509-2519
6. Gluckman E., Devergie A., Poros A., et al. Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT). Br J Haematol 51 (1982) 541-550
7. Pongtanakul B., Kumar Das P., Karen C., et al. Outcome of children with aplastic anemia treated with immunosuppressive therapy. Pediatr Blood Cancer 50 (2008) 52-57
8. Scheinberg P., Wu C.O., Nunez O., et al. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr 153 6 (2008 Dec) 814-819
9. Kojima S., Horibe K., Inaba J., et al. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol 111 (2000) 321-328
10. Kojima S., Ohara A., Tsuchida M., et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 100 (2002) 786-790
11. Frickhofen N., Heimpel H., Kaltwasser J.P., et al. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 101 (2003) 1236-1242
12. Kosaka Y., Yagasaki H., Sano K., et al. Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood 111 (2008) 1054-1059
13. Storb R., Blume K.G., O'Donnell M.R., et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant 7 (2001) 39-44
14. Champlin R.E., Horowitz M.M., van Bekkum D.W., et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 73 (1989) 606-613
15. Deeg H.J., Self S., Storb R., et al. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. Blood 68 (1986) 1363-1368
16. Camitta B.M., Thomas E.D., Nathan D.G., et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48 (1976) 63-70
17. Anasetti C., Doney K.C., Storb R., et al. Marrow transplantation for severe aplastic anemia: long-term outcome in fifty "untransfused" patients. Ann Intern Med 104 (1986) 461-466
18. Passweg J.R., Socie G., Hinterberger W., et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved?. Blood 90 (1997) 858-864
19. Niederwieser D., Pepe M., Storb R., et al. Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia. Br J Haematol 69 (1988) 23-28
20. McCann S., Bacigalupo A., Gluckman E., et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 13 (1994) 233-237
21. Champlin R.E., Perez W.S., Passweg J.R., et al. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood 109 (2007) 4582-4585
22. Locasciulli A., Oneto R., Bacigalupo A., et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. Haematologica 92 (2007) 11-18
23. Marsh J.C.W. Management of acquired aplastic anaemia. Blood Rev 19 (2005) 143-151
24. Kahl C., Leisenring W., Deeg H.J., et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol 130 (2005) 747-751
25. Locatelli F., Bruno B., Zecca M., et al. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft-versus-host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood 96 (2000) 1690-1697
26. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral-blood cells from hla-identical relatives in patients with hematologic cancers. N Engl J Med 344 (2001) 175-181
27. Couban S., Simpson D.R., Barnett M.J., et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 100 (2002) 1525-1531
28. Champlin R.E., Schmitz N., Horowitz M.M., et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 95 (2000) 3702-3709
29. Ringden O., Labopin M., Bacigalupo A., et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 20 (2002) 4655-4664
30. Eapen M., Logan B.R., Confer D.L., et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 13 (2007) 1461-1468
31. Blaise D., Kuentz M., Fortanier C., et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 18 (2000) 537-546
32. Li C.K., Yuen P.M., Chik K.W., et al. Allogeneic peripheral blood stem cell transplant in children. Med Pediatr Oncol 30 (1998) 147-151
33. Levine Je W.J., Kletzel M., Yanik G., et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Bone Marrow Transplant 25 (2000) 13-18
34. Watanabe T., Takaue Y., Kawano Y., et al. HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents. Biol Blood Marrow Transplant 8 (2002) 26-31
35. Schrezenmeier H., Passweg J.R., Marsh J.C.W., et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 110 (2007) 1397-1400
36. Eapen M., Horowitz M.M., Klein J.P., et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 22 (2004) 4872-4880
37. Marsh J.C.W., Ball S.E., Darbyshire P., et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123 (2003) 782-801
38. Bacigalupo A., Hows J., Gordon-Smith E.C., et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA-identical siblings: a report of the BMT Working Party. Bone Marrow Transplant 3 (1988) 531-535
39. Margolis D., Camitta B., Pietryga D., et al. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 94 (1996) 65-72
40. Henslee-Downey P.J., Abhyankar S.H., Parrish R.S., et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 89 (1997) 3864-3872
41. Kernan N.A., Bartsch G., Ash R.C., et al. Analysis of 462 Transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328 (1993) 593-602
42. Wagner J.L., Deeg H.J., Seidel K., et al. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-identical relatives: an update of the Seattle Experience 1. Transplantation 61 (1996) 54-61
43. Deeg H.J., Anasetti C., Petersdorf E., et al. Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, -B, -DRB matched unrelated donors [letter]. Blood 83 (1994) 3417-3418
44. Vassiliou G.S., Webb D.K., Pamphilon D., et al. Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. Br J Haematol 114 (2001) 701-705
45. Deeg H.J., O'Donnell M., Tolar J., et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 108 (2006) 1485-1491
46. Chan K., Li C., Worth L., et al. A fludarabine-based conditioning regimen for severe aplastic anemia. Bone Marrow Transplant 27 (2001) 125-128
47. Bacigalupo A., Locatelli F., Lanino E., et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 36 (2005) 947-950
48. Urban C., Benesch M., Sykora K.W., et al. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia. Bone Marrow Transplant 35 (2005) 591-594
49. Kumar R., Prem S., Mahapatra M., et al. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Bone Marrow Transplant 37 (2006) 745-749
50. Viollier R., Socie G., Tichelli A., et al. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 41 (2007) 45-50
51. Ohga S., Ichino K., Goto K., et al. Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning. Pediatr Transplant 10 (2006) 497-500
52. Kennedy-Nasser A.A., Leung K.S., Mahajan A., et al. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 12 (2006) 1277-1284
53. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
54. Neudorf S.M., Blatt J., Corey S., et al. Graft failure after an umbilical cord blood transplant in a patient with severe aplastic anemia [letter]. Blood 85 (1995) 2991-2992
55. Mao P., Zhu Z., Wang H., et al. Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia. Eur J Haematol 75 (2005) 430-435
56. Yoshimi A., Kojima S., Taniguchi S., et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 14 (2008) 1057-1063
57. Boiron J., Cotterêt S., Cony-Makhoul P., et al. Stable mixed chimerism without relapse after related allogeneic umbilical cord blood transplantation in a child with severe aplastic anemia. Bone Marrow Transplant 22 (1998) 819-821
58. Wagner J.E., Kernan N.A., Steinbuch M., et al. Allogeneic sibling umbilical cord blood transplantation in children with malignant and non-malignant disease. Lancet 346 (1995) 214-219
59. Chan K.W., McDonald L., Lim D., et al. Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. Bone Marrow Transplant 42 9 (2008) 589-595
60. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8 (2007) 735-748
61. Taniguchi T., and D'Andrea A.D. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107 (2006) 4223-4233
62. Guardiola P., Pasquini R., Dokal I., et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 95 (2000) 422-429
63. Wagner J.E., Eapen M., MacMillan M.L., et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 109 (2007) 2256-2262
64. Kutler D.I., Singh B., Satagopan J., et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101 (2003) 1249-1256
65. Rosenberg P.S., Alter B.P., and Ebell W. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Haematologica 93 (2008) 511-517
66. Alter B.P. Cancer in Fanconi anemia, 1927-2001. Cancer 97 (2003) 425-440
67. Gluckman E., Devergie A., Schaison G., et al. Bone marrow transplantation in Fanconi anaemia. Br J Haematol 45 (1980) 557-564
68. Berger R., Bernheim A., and Gluckman E.G. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 45 (1980) 565-568
69. Gluckman E., Devergie A., and Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 54 (1983) 431-440
70. Guardiola P., Socie G., Li X., et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 103 (2004) 73-77
71. Gluckman E., Auerbach A.D., Horowitz M.M., et al. Bone marrow transplantation for Fanconi anemia. Blood 86 (1995) 2856-2862
72. Socie G., Devergie A., Girinski T., et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 103 (1998) 249-255
73. Ayas M., Solh H., Mustafa M., et al. Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant 27 (2001) 139-143
74. Kohli-Kumar M., Morris C., DeLaat C., et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 84 (1994) 2050-2054
75. Farzin A., Davies S.M., Smith F.O., et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience. Br J Haematol 136 (2007) 633-640
76. Zanis-Neto J., Flowers M.E.D., Medeiros C.R., et al. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Br J Haematol 130 (2005) 99-106
77. Balci Y.I., Akdemir Y., Gumruk F., et al. CD-34 selected hematopoetic stem cell transplantation from HLA-identical family members for fanconi anemia. Pediatr Blood Cancer 50 (2008) 1065-1067
78. Ayas M., Al-Jefri A., Al-Seraihi A., et al. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience. Bone Marrow Transplant 42 (2008) S45-S48
79. Locatelli F., Zecca M., Pession A., et al. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica 92 (2007) 1381-1388
80. Tan P.-L., Wagner J.E., Auerbach A.D., et al. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 46 (2006) 630-636
81. Bitan M., Or R., Shapira M.Y., et al. Fludarabine-based reduced-intensity conditioning for stem cell transplantation of fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 12 (2006) 712-718
82. George B., Mathews V., Shaji R.V., et al. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia. Bone Marrow Transplant 35 (2005) 341-343
83. de la Fuente J., Reiss S., McCloy M., et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 32 (2003) 653-656
84. MacMillan M.L., Auerbach A.D., Davies S.M., et al. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol 109 (2000) 121-129
85. Yabe H., Inoue H., Matsumoto M., et al. Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia. Br J Haematol 134 (2006) 208-212
86. de Medeiros C., Bitencourt M., Zanis-Neto J., et al. Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution. Braz J Med Biol Res 39 (2006) 1297-1304
87. Chaudhury S., Auerbach A.D., Kernan N.A., et al. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol 140 (2008) 644-655
88. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 337 (1997) 373-381
89. Rosenberg P.S., Socie G., Alter B.P., et al. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105 (2005) 67-73
90. Gluckman E., Rocha V., Ionescu I., et al. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 13 (2007) 1073-1082
91. Boocock G.R.B., Morrison J.A., Popovic M., et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 33 (2003) 97-101
92. Ginzberg H., Shin J., Ellis L., et al. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr 135 (1999) 81-88
93. Smith O., Hann I., Chessells J., et al. Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol 94 (1996) 279-284
94. Mack D.R., Forstner G.G., Wilschanski M., et al. Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology 111 (1996) 1593-1602
95. Donadieu J., Leblanc T., Bader Meunier B., et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia: experience of the French Severe Chronic Neutropenia Study Group. Haematologica 90 (2005) 45-53
96. Vibhakar R., Radhi M., Rumelhart S., et al. Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. Bone Marrow Transplant 36 (2005) 855-861
97. Donadieu J., Michel G., Merlin E., et al. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French Neutropenia Registry. Bone Marrow Transplant 36 (2005) 787-792
98. Cesaro S., Oneto R., Messina C., et al. Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for Blood and Marrow Transplantation. Br J Haematol 131 (2005) 231-236
99. Hsu J., Vogelsang G., Jones R., et al. Bone marrow transplantation in Shwachman-Diamond syndrome. Bone Marrow Transplant 30 4 (2002) 255-258
100. Okcu F., Roberts W., and Chan K. Bone marrow transplantation in Shwachman-Diamond syndrome: report of two cases and review of the literature. Bone Marrow Transplant 21 (1998) 849-851
101. Tsai P., Sahdev I., Herry A., et al. Fatal cyclophosphamide-induced congestive heart failure in a 10-year-old boy with Shwachman-Diamond syndrome and severe bone marrow failure treated with allogeneic bone marrow transplantation. Am J Pediatr Hematol Oncol 12 (1990) 472-476
102. Fleitz J., Rumelhart S., Goldman F., et al. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome. Bone Marrow Transplant 29 (2002) 75-79
103. Sauer M., Zeidler C., Meissner B., et al. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. Bone Marrow Transplant 39 (2007) 143-147
104. Bhatla D., Davies S.M., Shenoy S., et al. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Marrow Transplant 42 (2008) 159-165
105. Mitchell J.R., Wood E., and Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402 (1999) 551-555
106. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 110 (2000) 768-779
107. Knight S., Vulliamy T., Copplestone A., et al. Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol 103 (1998) 990-996
108. Kirwan M., and Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet 73 (2008) 103-112
109. de la Fuente J., and Dokal I. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr Transplant 11 (2007) 584-594
110. Langston A., Sanders J., Deeg H., et al. Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol 92 (1996) 758-765
111. Yabe M., Yabe H., Hattori K., et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant 19 (1997) 389-392
112. Rocha V., Devergie G., Socié G., et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 103 (1998) 243-248
113. Dror Y., Freedman M.H., Leaker M., et al. Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita. Bone Marrow Transplant 31 (2003) 847-850
114. Ayas M., Al-Musa A., Al-Jefri A., et al. Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin. Pediatr Blood Cancer 49 (2007) 103-104
115. Gungor T., Corbacioglu S., Storb R., et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita. Bone Marrow Transplant 31 (2003) 407-410
116. Vlachos A., Ball S., Dahl N., et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 142 (2008) 859-876
117. Ball S.E., McGuckin C.P., Jenkins G., et al. Diamond-Blackfan anaemia in the UK: analysis of 80 cases from a 20-year birth cohort. Br J Haematol 94 (1996) 645-653
118. Campagnoli M.F., Garelli E., Quarello P., et al. Molecular basis of Diamond-Blackfan anemia: new findings from the Italian registry and a review of the literature. Haematologica 89 (2004) 480-489
119. Giri N., Kang E., Tisdale J.F., et al. Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond Blackfan anaemia. Br J Haematol 108 (2000) 167-175
120. Lipton J.M., Atsidaftos E., Zyskind I., et al. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer 46 (2006) 558-564
121. Roy V., Perez W.S., Eapen M., et al. Bone marrow transplantation for Diamond-Blackfan anemia. Biol Blood Marrow Transplant 11 (2005) 600-608
122. Mugishima H., Ohga S., Ohara A., et al. Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology. Pediatr Transplant 11 (2007) 601-607
123. + selected peripheral blood stem cells from an unrelated donor in an adult patient with Diamond-Blackfan anemia and secondary hemochromatosis. Bone Marrow Transplant 35 (2004) 99-100
124. Ostronoff M., Florencio R., Campos G., et al. Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia. Bone Marrow Transplant 34 (2004) 371-372
125. Lipton J., Federman N., Khabbaze Y., et al. Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol 23 (2001) 39-44
126. Vlachos A., Federman N., Reyes-Haley C., et al. Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Bone Marrow Transplant 27 (2001) 381-386
127. Ballmaier M., Germeshausen M., Schulze H., et al. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood 97 (2001) 139-146
128. King S., Germeshausen M., Strauss G., et al. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol 131 (2005) 636-644
129. Al-Ahmari A., Ayas M., Al-Jefri A., et al. Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT). Bone Marrow Transplant 33 (2004) 829-831
130. Lackner A., Basu O., Bierings M.L., et al. Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia. Br J Haematol 109 (2000) 773-775
131. MacMillan M., Davies S., Wagner J., et al. Engraftment of unrelated donor stem cells in children with familial amegakaryocytic thrombocytopenia. Bone Marrow Transplant 21 (1998) 735-737
132. Kudo K., Kato K., Matsuyama T., et al. Successful engraftment of unrelated donor stem cells in two children with congenital amegakaryocytic thrombocytopenia. Pediatr Hematol Oncol 24 (2002) 79-80
133. Yeşilipek H.V., Küpesiz A., et al. Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia. Bone Marrow Transplant 26 (2000) 571-572
134. Steele M., Hitzler J., Doyle J.J., et al. Reduced-intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7. Pediatr Blood Cancer 45 (2005) 212-216
135. Rosenberg P.S., Greene M.H., and Alter B.P. Cancer incidence in persons with Fanconi anemia. Blood 101 (2003) 822-826
136. Deeg H.J., Socie G., Schoch G., et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87 (1996) 386-392
137. Deeg H.J., Leisenring W., Storb R., et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 91 (1998) 3637-3645
138. Kolb H.J., Socie G., Duell T., et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Ann Intern Med 131 (1999) 738-744
139. Witherspoon R.P., Storb R., Pepe M., et al. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone [letter]. Blood 79 (1992) 289-291
140. Eapen M., Ramsay N.K.C., Mertens A.C., et al. Late outcomes after bone marrow transplant for aplastic anaemia. Br J Haematol 111 (2000) 754-760
141. Sanders J.E. Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant 8 Suppl 5 (2004) 39-50
142. Sanders J.E. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 41 (2007) 223-227
143. Ades L., Mary J.-Y., Robin M., et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 103 (2004) 2490-2497
144. Leiper A.D. Non-endocrine late complications of bone marrow transplantation in childhood: part I. Br J Haematol 118 (2002) 3-22